The antibody market has become a cornerstone of modern biotechnology and pharmaceutical industries, underpinning a vast array of diagnostic and therapeutic applications. Antibodies, which are proteins ...

Vancouver-based biotech firm AbCellera Biologics Inc. (NASDAQ:ABCL) has announced a major milestone in its fight against ...

Cell and gene therapies harbor great hopes for biomedicine. They are becoming increasingly important for diseases that are ...

These antibodies destroy red blood cells faster than your body can make them. Cold autoimmune hemolytic anemia. Also known as cold agglutinin disease (CAD), this is when your body makes specific ...

The lack of funding is expected to set back decades' worth of progress against HIV, according to public health experts.

The startup is the latest beneficiary of investors’ appetite for protein-degrading technology, which offers a way to reach ...

It’s GlycoEra’s time to shine. The biotech has closed a series B fundraise clocking in at $130 million, with the funds set to ...

A live webcast of the Company’s presentation may be accessed under “News and Events” in the Investors section of the Dianthus Therapeutics website.

Plasma therapy is one of several different experimental longevity procedures that involve blood transfers, including platelet ...

In January, the Trump administration halted disbursement of funds from the President’s Emergency Plan for AIDS Relief, known ...

“The FDA’s decision to grant Fast Track designation for TEV-53408, an investigational anti-IL-15 antibody therapy, reflects the promising nature of the treatment and the urgent unmet need of people ...